PS
Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
651
Mobileye
MBLY
$11.3B
|
AP
Alexander Potter
| $13.88 | $17 |
22%
upside
| Neutral |
20 Mar ‘25
5 months ago |
|
652
Stellantis
STLA
$25.3B
|
AP
Alexander Potter
| $8.75 | $13 |
49%
upside
| Neutral |
20 Mar ‘25
5 months ago |
|
653
ACV Auctions
ACVA
$1.8B
|
AP
Alexander Potter
| $10.43 | $20 |
92%
upside
| Overweight |
20 Mar ‘25
5 months ago |
|
654
Monopar Therapeutics
MNPR
$265M
|
BA
Biren Amin
| $42.90 | $76 |
77%
upside
| Overweight |
19 Mar ‘25
5 months ago |
|
655
Ultragenyx Pharmaceutical
RARE
$3.02B
|
AB
Allison Bratzel
| $31.29 | $115 |
268%
upside
| Overweight |
17 Mar ‘25
5 months ago |
|
656
Akebia Therapeutics
AKBA
$777M
|
AB
Allison Bratzel
| $2.93 | $6 |
105%
upside
| Overweight |
14 Mar ‘25
6 months ago |
|
657
Xponential Fitness
XPOF
$294M
|
KW
Korinne Wolfmeyer
| $8.38 | $9 |
7%
upside
| Neutral |
14 Mar ‘25
6 months ago |
|
658
Manhattan Associates
MANH
$12.8B
|
QG
Quinton Gabrielli
| $212.31 | $200 |
6%
downside
| Overweight |
14 Mar ‘25
6 months ago |
|
659
SentinelOne
S
$5.95B
|
RO
Rob Owens
| $17.84 | $28 |
57%
upside
| Overweight |
13 Mar ‘25
6 months ago |
|
660
United Bankshares
UBSI
$5.36B
|
SS
Stephen Scouten
| $37.83 | $38.50 |
2%
upside
| Neutral |
12 Mar ‘25
6 months ago |
|
|
SAIL
661
SailPoint, Inc. Common Stock
SAIL
$11B
|
RO
Rob Owens
| $19.81 | $30 |
51%
upside
| Overweight |
10 Mar ‘25
6 months ago |
|
662
Xeris Biopharma Holdings
XERS
$1.26B
|
DA
David Amsellem
| $7.81 | $4 |
49%
downside
| Neutral |
7 Mar ‘25
6 months ago |
|
663
Lexicon Pharmaceuticals
LXRX
$392M
|
YR
Yasmeen Rahimi
| $1.08 | $6 |
456%
upside
| Overweight |
7 Mar ‘25
6 months ago |
|
664
Sight Sciences
SGHT
$179M
|
MO
Matt O'Brien
| $3.41 | $3.50 |
3%
upside
| Neutral |
6 Mar ‘25
6 months ago |
|
665
ALX Oncology
ALXO
$62.7M
|
CR
Christopher Raymond
| $1.17 | $9 |
669%
upside
| Overweight |
6 Mar ‘25
6 months ago |
|
666
Indivior
INDV
$3.04B
|
DA
David Amsellem
| $24.39 | $13 |
47%
downside
| Overweight |
6 Mar ‘25
6 months ago |
|
667
Viatris
VTRS
$11.9B
|
DA
David Amsellem
| $10.24 | $10 |
2%
downside
| Neutral |
5 Mar ‘25
6 months ago |
|
668
Alignment Healthcare
ALHC
$3.26B
|
JT
Jessica Tassan
| $16.45 | $21 |
28%
upside
| Overweight |
4 Mar ‘25
6 months ago |
|
669
Cytek Biosciences
CTKB
$476M
|
DW
David Westenberg
| $3.74 | $8 |
114%
upside
| Overweight |
4 Mar ‘25
6 months ago |
|
670
ACNB Corp
ACNB
$470M
|
JC
Justin Crowley
| $44.87 | $50 |
11%
upside
| Overweight |
3 Mar ‘25
6 months ago |
|
671
Check Point Software Technologies
CHKP
$20.9B
|
RO
Rob Owens
| $194.24 | $260 |
34%
upside
| Overweight |
3 Mar ‘25
6 months ago |
|
672
Coca-Cola
KO
$292B
|
ML
Mike Lavery
| $67.82 | $80 |
18%
upside
| Overweight |
28 Feb ‘25
6 months ago |
|
673
TechnipFMC
FTI
$16.8B
|
DP
Derek Podhaizer
| $40.89 | $40 |
2%
downside
| Overweight |
28 Feb ‘25
6 months ago |
|
|
ALEX
674
Alexander & Baldwin
ALEX
$1.36B
|
AG
Alexander Goldfarb
| $18.68 | $24 |
28%
upside
| Overweight |
28 Feb ‘25
6 months ago |
|
675
SITE Centers
SITC
$468M
|
AG
Alexander Goldfarb
| $8.92 | $19 |
113%
upside
| Overweight |
28 Feb ‘25
6 months ago |
|